Macrophages in Tumor Microenvironments and the Progression of Tumors
Top Cited Papers
Open Access
- 1 January 2012
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2012, 1-11
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.Keywords
Funding Information
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
This publication has 121 references indexed in Scilit:
- Tumor-associated Macrophages (TAM) and Inflammation in Colorectal CancerCancer Microenvironment, 2010
- Alternatively activated macrophages in infection and autoimmunityJournal of Autoimmunity, 2009
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activationHuman Immunology, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppressionMolecular Immunology, 2008
- Mechanisms of macrophage activation in obesity-induced insulin resistanceNature Clinical Practice Endocrinology & Metabolism, 2008
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Inflammation and cancerNature, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002